{'fraction_non_alphanumeric': 0.016181229773462782, 'fraction_numerical': 0.0, 'mean_word_length': 6.548780487804878, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Blood test monitoring of immunomodulatory therapy in inflammatory disease

Immunomodulation is the cornerstone of treatment in many immune mediated inflammatory disorders, including inflammatorybowel disease, autoimmune rheumatic disease, and inflammatory skin diseases. Most require pre-treatment screening blood tests and regular blood test monitoring thereafter to detect potential toxicity. This article seeks to provide a simplified overview of blood test monitoring requirements, and is aimed at general practitioners who, increasingly, are taking responsibility for monitoring and prescribing these medications.